Profile and story
Amilia is an 11-year-old girl who is bright and full of life. She loves doing crafts, drawing, playing Skip-Bo, and—most of all—dancing with her friends. At school, art and math are among her favorite subjects.
In April 2025, her life was turned upside down when she was diagnosed with acute lymphoblastic leukemia. Just as she was about to head to her dance class, medical test results led her family to the Montreal Children’s Hospital instead, where she has since been monitored and treated. Her treatments have forced her to put school, travel, and dance on hold, and to spend a lot of time away from her friends.
Her journey has also been marked by a serious complication. Following chemotherapy, Amilia developed severe pancreatitis that caused necrosis of her pancreas, and she now lives with type 1 diabetes. This reality underscores the importance of advancing research on pediatric cancers—not only to develop increasingly effective treatments but also to better understand and reduce their short- and long-term effects.
Amilia, who is still undergoing treatment today, takes each day as it comes, surrounded by her family and friends. Her biggest dream? To go to Italy. And if she could choose a superpower, she’d like to be able to stop time.
For her family, the Charles-Bruneau Foundation represents the very possibility of advancing science for children diagnosed with cancer.
By participating in the Coupe Charles-Bruneau in Montreal, each team helps support this research and improve the treatments available to children like Amilia.
And to everyone who chooses to get involved, Amilia has a few words that simply sum up why this effort matters: “Thank you for helping children like me!”